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DPY19L2 Deletion as a Major Cause of Globozoospermia
Isabelle Koscinski,1,2,11 Elias ElInati,2,11 Camille Fossard,2 Claire Redin,2 Jean Muller,2,3
Juan Velez de la Calle,4 Franc¸oise Schmitt,5 Mariem Ben Khelifa,6 Pierre Ray,6,7,8 Zaid Kilani,9
Christopher L.R. Barratt,10 and Ste´phane Viville1,2,*
Globozoospermia, characterized by round-headed spermatozoa, is a rare (< 0.1% in male infertile patients) and severe teratozoospermia
consisting primarily of spermatozoa lacking an acrosome. Studying a Jordanian consanguineous family in which five brothers were diag-
nosed with complete globozoospermia, we showed that the four out of five analyzed infertile brothers carried a homozygous deletion of
200 kb on chromosome 12 encompassing only DPY19L2. Very similar deletions were found in three additional unrelated patients, sug-
gesting thatDPY19L2 deletion is a major cause of globozoospermia, given that 19% (4 of 21) of the analyzed patients had such deletion.
The deletion is most probably due to a nonallelic homologous recombination (NAHR), because the gene is surrounded by two low copy
repeats (LCRs). We found DPY19L2 deletion in patients from three different origins and two different breakpoints, strongly suggesting
that the deletion results from recurrent events linked to the specific architectural feature of this locus rather than from a founder effect,
without fully excluding a recent founder effect. DPY19L2 is associated with a complete form of globozoospermia, as is the case for the
first two genes found to be associated with globozoospermia, SPATA16 or PICK1. However, in contrast to SPATA16, for which no preg-
nancy was reported, pregnancies were achieved, via intracytoplasmic sperm injection, for two patients with DPY19L2 deletion, who
then fathered three children.In a previous work, we described the identification of
a mutation in SPATA16 (MIM 609856) responsible for
a complete form of globozoospermia (MIM 102530) in
three affected brothers of an Ashkenazi Jewish family.1
We report here the involvement of DPY19L2 on chromo-
some 12 in cases of complete forms of globozoospermia.
Our study started with the analysis of a Jordanian family
of ten siblings, including two sisters and three brothers
whowere naturally fertile (all of themhaving 3–7 children)
and five affected brothers with a complete form of globo-
zoospermia (Figure 1A). Intracytoplasmic sperm injection
(ICSI) was performed for the five brothers at the Farah
Hospital, Amman, Jordan, and despite a total of 20 cycles
there was only one single-term pregnancy, as well as two
miscarriages.2 Because of the consanguineous marriage of
the grandparents, who were first-degree cousins, we postu-
lated that the genetic abnormality was transmitted as an
autosomal-recessive disorder. Four of the five affected indi-
viduals, Globo1 to Globo4 (IV-1 to IV-4 in Figure 1A), and
all three fertile individuals, brothers B1 to B3 (IV-5 to IV-7
in Figure 1A), consented to give blood samples for research
(Figure 1A).
We performed a genome-wide scan analysis of all seven
brothers, using 10K SNP arrays (Affymetrix Genechip).
Regions of homozygosity were defined by the presence of
at least 25 consecutive homozygous SNPs. We identified
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344 The American Journal of Human Genetics 88, 344–350, March 1four affected brothers; the fertile brothers were heterozy-
gous for this region (Figure 1B). This region of about
6.4 Mb on chromosome 12 (positions 63060074 to
69409722, on the GRCh37/hg19 version of the human
genome, corresponding to SNPs rs345945 and rs2172989;
see Table S1 available online) contains 101 genes, 40 of
which are expressed in the testis, according to the UCSC
Genome Browser3 (Table S2), and thus are potentially
involved in spermatogenesis. We selected DPY19L2 as
the most plausible candidate gene because of its predomi-
nant testis expression and its potential involvement in
cellular polarization.4 The spermatozoon is a highly polar-
ized cell, and the initial stages of spermiogenesis involve
polarization of the round spermatid. Functional studies
of DPY-19 (an ortholog of DPY19L2) in C. elegans high-
lighted its role in the establishment of polarity in the
migrating neuroblasts.4 DPY19L2 is composed of 22 exons
and belongs to the DPY19L family5 coding for proteins
harboring 9–11 predicted transmembrane domains. This
gene family, encompassing four genes and six pseudo-
genes, has a complex evolutionary history involving
several duplications and pseudogenizations.5 In particular,
DPY19L2 stems from an initial duplication of DPY19L1
on chromosome 7, followed by a recent relocalization on
chromosome 12 in humans, leaving the initial copy on
chromosome 7 as a pseudogene (DPY19L2P1). This evolu-
tionary event may rely on the presence of low copy repeatssbourg, F-67000 France; 2Institut de Ge´ne´tique et de Biologie Mole´culaire
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Figure 1. Pedigree and Linkage Analysis of the Jordanian Family
(A) Jordanian pedigree showing second-degree consanguinity.
(B) SNP array results of the four infertile and three fertile brothers
for the region of chromosome12. Shared regions of homozygosity
are visualized by the HomoSNP software, which displays one
patient per line. The areas of homozygosity with 25 or more
SNPs are black, whereas homozygosity regions defined by 15–25
consecutive SNPs are gray. Regions of heterozygosity are light
gray. The four affected siblings, Globo1 to Globo4 (IV-1 to IV-4),
share a region of homozygosity of 6.4 Mb on chromosome 12,
which is not shared by the three fertile brothers, B1 to B3 (IV-5
to IV-7).(LCRs) surrounding the DPY19L2 locus (Figure 2A).
Because of the high level of conservation between
DPY19L2 and DPY19L2P1,5 the design of DPY19L2-
specific oligonucleotides was complex. PCR conditions
were optimized for exons 2, 7, 9, 10, 13, 17, and 21, result-
ing in specific amplifications in controls but never in the
patients, suggesting a large deletion of the whole gene
(Figure 2B). In order to better characterize the two
described LCRs surrounding DPY19L2, we performed
a Blastn analysis6 using a 100 kb region up- and
downstream of the gene. This approach revealed a highly
similar duplicated region (96.5% identity), corresponding
to the two identified LCRs (Figure 2B). The telomeric LCR
(named here LCR1) is 26,998 bp long and is located
upstream of exon 1 (64,119,249–64,146,247), and the
centromeric LCR (named here LCR2) is 28,200 bp
long and starts ~1000 bp downstream of exon 22
(63,923,419–63,951,619). In order to define as precisely
as possible the breakpoints within the recombined LCRs,
specific oligonucleotides were designed to walk on both
sides of the deletion (Figures 2B–2D and Table S4). This
allowed us to define a first target segment of 107 bp, which
we named DPY19L2-BP1. Further refinement is not
possible because of the high percentage of identity shared
by the two LCRs (Figure 2E and Figure S1). The exact size of
the deletion is 195,150 bp. All three healthy brothers B1,
B2 and B3 are homozygous wild-type.
The DPY19L2 deletion was then screened in 24 globo-
zoospermic patients from 20 independent families, origi-
nating from Algeria, France, Iran, Italy, Lybia, Morocco,
and Tunisia. Twelve of them had a complete form of globo-
zoospermia, and six had a partial form (defined as between
20% and 90% of the spermatozoa having round heads7).The AmeriFor the remaining two, we did not have any detailed infor-
mation (Table 1). We found a similar deletion of DPY19L2
in three unrelated cases presenting with a complete form
of globozoospermia (Figures 2C and 2D), two cases origi-
nating from France (Globo17 and Globo18) and one
familial case from Algeria comprising two brothers
(Globo7 and Globo8). One of the French patients
(Globo17) had two children, born after ICSI treatment
(Table 1). We localized the breakpoints for all three
additional patients. For Globo18, the deletion breakpoints
are located, as suggested by the PCR walk (Figure 2D), in
the same 107 bp LCR area (DPY19L2-BP1) as that of the
Jordanian family. Both of his parents are heterozygous
for the deletion, as demonstrated by the possibility of
amplifying both the recombined region (i.e., absence
of DPY19L2) and exon 10 (i.e., at least one copy of
DPY19L2) (Figure 2C). The analysis of Globo7 and Globo8
allowed us to identify a different breakpoint, which we
named DPY19L2-BP2, (Figure 2D), in an area of 296 bp,
positioned 169 bp 30 to the 107 bp area. Interestingly,
Globo17 is a heterozygous composite, because the two
different breakpoints (DPY19L2-BP1 and DPY19L2-BP2)
could be observed (Figure 2D). The analysis of his parents
showed their heterozygous status for the deletion and
allowed us to detect the two different breakpoints on
each allele. The maternal allele carries DPY19L2-BP2
and the paternal allele carries DPY19L2-BP1. For both
parents we could amplify exon 10, demonstrating the
presence of at least one copy of DPY19L2 (Figure 2C).
The deletion of DPY19L2 was not found in the homozy-
gous state in 105 European-descent males and 101 fertile
Jordanian males.
Several studies have reported copy-number variants
(CNVs) at the genome-scale level that are fully available
and searchable in databases such as the Database of
GenomicVariants (DGV).8DGVreports, in its latest version
(November 2010), 66,741 CNVs from 42 studies. At the
DPY19L2 locus, DGVreferences 29CNVs that are described
by 12 different studies encompassing different ethnic
groups (Figure 3 and Table S3). Considering only the nonre-
dundant CNVs identified in non-BAC (bacterial artificial
chromosome) studies and those that are fully overlapping
DPY19L2, only five studies can be considered.8–13 The
detailed inventory of the CNVs revealed 64 duplications
and22heterozygous deletions out of 4886 patients studied,
whereas no homozygous deletion was reported (Table 2).
Interestingly, about three times more duplications than
deletions can be observed at this locus. This is surprising
because in most of the cases studied, deletions are more
frequent than duplications.14We do not have a clear expla-
nation for this, but it would be of interest to determine
whether the heterozygous status is affecting male fertility,
which would explain the selection against deletion. The
frequency of heterozygous deletion in the surrounding
region of DPY19L2 is 1/222, implying an overall disease
risk of ~1/200,000 (see Table 2). Examining the localization
of the CNVs, one can observe that all deletion breakpointscan Journal of Human Genetics 88, 344–350, March 11, 2011 345
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Figure 2. Analysis of DPY19L2
(A) Schematic representation of DPY19L2 flanked by two LCRs, LCR1 and LCR2. LCR1 is located upstream of the gene and LCR2
downstream. Different sequences were amplified on both sides of the gene in order to determine the breakpoints: ‘‘a,’’ ‘‘b,’’ and ‘‘c’’
sequences are localized in LCR1, whereas ‘‘d’’ and ‘‘e’’ sequences are localized in LCR2. Mismatches between the two LCRs sequences
are represented by (*) in the 50 side and by (.) in the 30 side.
(B) PCR results ofDPY19L2 exons and flanking regions. Patients Globo1, Globo7, Globo17, and Globo18 are deleted for exons 2, 7, 9, 10,
13, 17, and 21, whereas the positive control showed an amplification of all of these exons. All patients showed specific amplifications for
region ‘‘a’’ in LCR1 and region ‘‘e’’ in LCR2. Globo1 and Globo18 are missing region ‘‘b’’ in LCR1, which is not the case for Globo7 and
Globo17. Globo7 is the only patient missing region ‘‘d’’ in LCR2. A DNA ladder was included on both sides of each gel for accurate deter-
mination of the PCR band size.
(C) PCR of DPY19L2 breakpoints. This PCR was performed with the use of the ‘‘LCR1a forward’’ and ‘‘DPY19L2-BP reverse’’ primers
(Table S4). The four globozoospermic patients showed a fragment of 1700 bp. The fertile brother (B1, IV-5 in Figure 1A) is homozygous
wild-type, because no fragment was amplified, whereas parents of Globo18 (P1 and P2) and Globo17 (P3 and P4) are heterozygous.
A fertile man (positive control) was used as control of the PCR specificity. Amplification of exon 10 (lower panel) was used to control
the presence or absence of DPY19L2.
(D) Table summarizing the PCR results of the four patients: (þ) indicates presence of a PCR band at the corresponding size, and (-)
indicates absence of a PCR band.
(E) Schematic representation of the breakpoint area determined for Globo1, Globo18, and the paternal allele of Globo17. The breakpoint
area (DPY19L2-BP1) identified by PCR and sequencing is defined between the two discontinued lines and represented by a hatched box
in the recombined LCR.
(F) Schematic representation of the homologous recombination that occurred in Globo7 and the maternal allele of Globo17. The
breakpoint area (DPY19L2-BP2) identified by PCR and sequencing is defined between the two discontinued lines and represented by
a hatched box in the recombined LCR.recorded in DGV fall into the two LCRs, and this is also true
for most of the duplications (Figure 3).
Considering the presence of highly conserved LCRs
surrounding DPY19L2, the most probable mechanism to
explain the multiple occurrence of this deletion would be
NAHR between highly similar sequences. Indeed, such
a mechanism has been reported for a large number of
disorders involving deletions, duplications, inversions, or
gene fusions15–17 (reviewed in14). It is estimated that this
is one of the most common mechanisms responsible for
genomic disorders. So far, no obvious founder effect has
been described for genetic disorders involving NAHR.14
That we found the DPY19L2 deletion in patients from
three different origins (the two French cases are not known
to be related), that two different breakpoints were
observed, and that Globo18 is not sharing the same haplo-
type of the Jordanian brothers (Table S1) strongly suggest
that the deletion results from recurrent events linked to346 The American Journal of Human Genetics 88, 344–350, March 1the specific architectural feature of this locus rather than
from a founder effect, without fully excluding a recent
founder effect. It is worth noting that the two identified
breakpoints are located near an Alu repeat (AluSq2), one
being fully included in this repeated element (Figure S1).
Interestingly, the patients with DPY19L2 deletion
present a complete globozoospermia yet have normal or,
in one case (Globo8), near-normal concentration of sperm
(Table 1). This contrasts with the case in which SPATA16 is
mutated, suggesting that DPY19L2 may disrupt only sper-
miogenesis and not germ cell proliferation and meiosis. It
should also be noted that, despite the testicular expression
of the other three members of the DPY19L family,5 it does
not appear that there is functional redundancy. No homo-
zygosity was found for the loci of the other functional
DPY19L genes.
We selected DPY19L2 as the primary candidate linked to
globozoospermia in our Jordanian family because of its1, 2011
Table 1. List of Globozoospermic Patients
Patient Origin SNP Screening
Sperm Concentration
(Million/mL)
Progressive
Motility (%)
Acrosome less
Morphology (%)
Fertilization Attempts
and Results
Complete Globozoospermia
Globo1 Jordan Yes 52 22 100 6 ICSI failed
Globo2 Jordan Yes 223 4 100 3 ICSI failed
Globo3 Jordan Yes 118 4 100 4 ICSI failed
Globo4 Jordan Yes 22 30 100 3 ICSI failed (1 miscarriage)
Globo5 France No ND ND 100 ND
Globo6 France No ND ND 100 ND
Globo7 Algeria No 90 10 100 ND
Globo8 Algeria No 13.2 2 100 ND
Globo9 France No 0.35 ND 100 1 ICSI failed
Globo10 France Yes 38 ND 100 1 ICSI succeeded
Globo11 France Yes 109 40 100 2 ICSI failed
Globo12 ND No ND ND 100 DSI
Globo13 Iran No 10.5 ND 100 ND
Globo14 Tunisia No 52.6 25 100 ND
Globo15 Tunisia No ND ND 100 1 ICSI failed
Globo16 Libya No 4 8 100 3 ICSI failed
Globo17 France Yes 78 45 100 IMSI succeeded twice
Globo18 France Yes 71 30 100 ND
Partial Globozoospermia
Globo19 Italy No 50 ND ND 1 ICSI failed
Globo20 France Yes 0.6 ND 84 1 IUI þ 3 ICSI failed
Globo21 France Yes 2 ND ND 2 ICSI failed
Globo22 Morocco No ND ND ND ND
Globo23 France Yes ND ND 95 1 ICSI succeeded
Globo24 France Yes ND ND 98 1 ICSI succeeded
Globo25 Tunisia No 59 50 88 ND
Globo26 Tunisia No 100 49 99 ND
Globo27 ND No ND ND ND ND
Globo28 ND No ND ND ND ND
Abbreviations are as follows: ND, not determined; ICSI, intracytoplasmic sperm injection; IUI, intrauterine insemination; IMSI, intracytoplasmic morphologically
selected sperm injection; DSI, donor sperm insemination.testicular expression and function of the DPY-19 ortholog
in C. elegans, involved in the polarization of neuroblasts.4
This would suggest that DPY19L2 is not directly involved
in the biogenesis of the acrosome, as for SPATA161 or
PICK1 (MIM 605926),18,19 but rather in preceding steps
associated with, for example, the polarity of the spermatid,
therefore allowing the correct positioning of the different
organelles such as the acrosome or the flagella. However,
this hypothesis is not supported by the examination of
the immature germ cells in the semen of three globozoo-
spermic patients (Globo7, Globo17, and Globo18). ForThe AmeriGlobo7, all stages of spermatogenesis could be observed
(Figure 4A) and there was no obvious abnormality in the
earlier stages of germ cells. In contrast, no proacrosomal
vesicle was observed in the round spermatids, yet they
appeared correctly polarized. Indeed, the polarization of
the spermatid was indicated by the correct positioning
of the chromatoid body (in the area of the attachment of
the flagellum to the spermatid nucleus) observed in elon-
gating spermatids. In Globo17 and Globo18 semen
samples, we observed elongating spermatids as well as
spermatozoa that are comparable to that of Globo7can Journal of Human Genetics 88, 344–350, March 11, 2011 347
Figure 3. CNVs at the DPY19L2 Locus
CNVs are displayed as rectangles according to the following scheme: gains are drawnwith hatched lines, losses with plain rectangles, and
vertical lines are used when both gains and losses are observed. The CNVs excluded from the count are colored in gray. LCR1 and LCR2
are displayed as dark gray rectangles on top of the gene representation.(Figures 4C–4E). In contrast to what is observed in
C. elegans, the function of DPY19L2 does not seems to be
involved in the polarization of the spermatozoa but,
rather, in the formation of the acrosome.
DPY19L2 is the third gene identified as being associated
with globozoospermia1,19 and, according to our data, the
most frequently mutated in this phenotype. Indeed, in
our series of 21 unrelated cases, we identified four indi-
vidual cases, meaning that the DPY19L2 deletion is found
in 19% of the globozoospermic cases. Looking at the
frequency of heterozygous deletion in control popula-
tions, we would expect an incidence of 1/200,000 for
homozygous individuals, whereas the incidence of globo-
zoospermia is estimated at less than 0.1% in infertile
males.7 Although we cannot fully exclude a positioning
effect, we do not believe that this could explain the
observed phenotype, because the four genes surrounding
the DPY19L2 locus (two centromeric: AVPR1A and
PPM1H; two telomeric: TMEM5 and SRGAP1) are not ex-
pressed in the testis and their function has no relation
with cell polarity or acrosome formation.
Considering that round-headed spermatozoa do not
have a higher incidence of chromosomal abnormali-
ties20–22 and that pregnancy can be obtained through
ICSI, albeit at a low frequency,2,23–26 it is reasonable to
propose ICSI treatment for all globozoospermic patients.Table 2. CNV Frequency of Individuals at the DPY19L2 Locus and Expe
Pinto et al.11 de Smith et al.10 Conrad et al.9 Itsara et
Gain 2 1 4 22
Loss (Htz) 0 3 0 5
Population 506 50 450 1854
348 The American Journal of Human Genetics 88, 344–350, March 1It will be interesting to enlarge the cohort of patients and
establish which conditions are able to give rise to live
births. Indeed, so far, no pregnancies have been obtained
with patients carrying a SPATA16 mutation1 (data not
shown), in contrast to patients with DPY19L2 deletion.
Such an analysis may suggest that a genetic test would
assist in determining the best option for treatment.
Our strategy has proven its interest and should be
extended to other countries, given that family clustering
of male infertility cases has been found in other studies
and appears to be related to patterns of consanguineous
marriage over generations.27,28Supplemental Data
Supplemental Data include Supplemental Material and Methods,
four tables, and one figure and can be found with this article on-
line at http://www.cell.com/AJHG.Acknowledgments
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Figure 4. Seminal Germ Cells in Patients with DPY19L2 Deletion
(A) Detailed seminal germ cell of Globo7. There is no evidence of defective spermatogenesis in immature germ cells; the spermatid
polarization and elongation is consistent with controls: e.g., the correct positioning of the chromatid body (blue arrows), except for
the absence of the acrosomal vesicle.
(B) Spermatozoa and spermatids of fertile controls. The acrosome is clearly observed in spermatozoa and elongating spermatid (arrows).
(C–E) Spermatozoa and spermatid of Globo17, Globo18, and Globo7, respectively. The spermatozoa present the typical round head and
an absence of acrosome. No evident polarization abnormality in seminal spermatids was observed in the globozoospermic patients.(Limoges)—who have sent us samples from globozoospermic
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